TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
34.58
-0.80 (-2.26%)
At close: Apr 28, 2026, 4:00 PM EDT
34.66
+0.08 (0.23%)
Pre-market: Apr 29, 2026, 9:23 AM EDT
TG Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 5,107 | 4,358 | 4,320 | 2,416 | 1,584 | 2,488 | |
| Market Cap Growth | -11.44% | 0.89% | 78.80% | 52.51% | -36.33% | -62.88% | |
| Enterprise Value | 5,219 | 4,481 | 4,233 | 2,297 | 1,491 | 2,159 | |
| Last Close Price | 34.58 | 29.81 | 30.10 | 17.08 | 11.83 | 19.00 | |
| PE Ratio | 12.48 | 9.75 | 184.75 | 190.66 | - | - | |
| Forward PE | 25.92 | 20.29 | 45.21 | - | - | - | |
| PS Ratio | 8.29 | 7.07 | 13.13 | 10.34 | 568.84 | 371.96 | |
| PB Ratio | 7.65 | 6.73 | 19.43 | 15.05 | 27.04 | 10.49 | |
| P/TBV Ratio | 7.88 | 6.73 | 19.43 | 15.05 | 27.41 | 10.53 | |
| EV/Sales Ratio | 8.47 | 7.27 | 12.87 | 9.83 | 535.24 | 322.82 | |
| EV/EBITDA Ratio | 42.30 | 36.32 | 100.79 | 110.20 | - | - | |
| EV/EBIT Ratio | 42.32 | 36.34 | 100.95 | 111.33 | - | - | |
| Debt / Equity Ratio | 0.39 | 0.39 | 1.14 | 0.69 | 1.42 | 0.34 | |
| Debt / EBITDA Ratio | 2.03 | 2.03 | 5.74 | 4.82 | - | - | |
| Net Debt / Equity Ratio | 0.17 | 0.17 | -0.25 | -0.66 | -1.34 | -0.99 | |
| Net Debt / EBITDA Ratio | 0.91 | 0.91 | -1.35 | -5.10 | 0.36 | 0.68 | |
| Net Debt / FCF Ratio | -4.50 | -4.50 | 1.40 | 3.39 | 0.45 | 0.80 | |
| Asset Turnover | 0.75 | 0.75 | 0.73 | 0.89 | 0.01 | 0.01 | |
| Inventory Turnover | 0.85 | 0.85 | 0.51 | - | - | - | |
| Quick Ratio | 2.91 | 2.91 | 4.85 | 5.00 | 3.04 | 4.84 | |
| Current Ratio | 4.10 | 4.10 | 6.25 | 5.92 | 3.16 | 5.06 | |
| Return on Equity (ROE) | 102.75% | 102.75% | 12.21% | 11.57% | -151.36% | -92.03% | |
| Return on Assets (ROA) | 9.39% | 9.39% | 5.78% | 4.93% | -47.61% | -42.87% | |
| Return on Invested Capital (ROIC) | 16.55% | 26.63% | 34.84% | 116.52% | - | - | |
| Return on Capital Employed (ROCE) | 13.60% | 13.60% | 8.60% | 7.50% | -155.50% | -109.70% | |
| Earnings Yield | 8.76% | 10.26% | 0.54% | 0.52% | -14.13% | -13.99% | |
| FCF Yield | -0.49% | -0.57% | -0.94% | -1.30% | -11.12% | -11.90% | |
| Buyback Yield / Dilution | -0.67% | -0.67% | -7.96% | -9.67% | -2.41% | -14.64% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.